Lataa...
Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS
Therapeutic monoclonal antibodies (mAbs) have made a tremendous impact in treating patients with various diseases. MAbs are designed to target specifically a cell and illicit a response from the immune system to destroy the cell. As originator mAb drug patents are coming to an end, generic pharmaceu...
Tallennettuna:
| Julkaisussa: | Curr Pharm Biotechnol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4959040/ https://ncbi.nlm.nih.gov/pubmed/27033511 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|